A detailed history of Nisa Investment Advisors, LLC transactions in Xencor Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 927 shares of XNCR stock, worth $24,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
927
Previous 831 11.55%
Holding current value
$24,157
Previous $15,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$15.7 - $21.65 $1,507 - $2,078
96 Added 11.55%
927 $18,000
Q2 2024

Jul 19, 2024

BUY
$18.21 - $24.5 $13,020 - $17,517
715 Added 616.38%
831 $15,000
Q1 2024

May 01, 2024

BUY
$18.65 - $26.52 $1,603 - $2,280
86 Added 286.67%
116 $2,000
Q4 2023

Jan 25, 2024

SELL
$16.53 - $21.42 $6,446 - $8,353
-390 Reduced 92.86%
30 $0
Q3 2023

Nov 02, 2023

BUY
$20.08 - $25.39 $7,730 - $9,775
385 Added 1100.0%
420 $8,000
Q2 2023

Aug 11, 2023

SELL
$24.77 - $29.9 $25,017 - $30,199
-1,010 Reduced 96.65%
35 $0
Q3 2022

Nov 07, 2022

BUY
$24.62 - $32.44 $1,107 - $1,459
45 Added 4.5%
1,045 $29,000
Q2 2022

Aug 03, 2022

BUY
$19.74 - $29.01 $19,740 - $29,010
1,000 New
1,000 $27,000
Q1 2022

Apr 29, 2022

SELL
$26.68 - $41.63 $249,751 - $389,698
-9,361 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$33.67 - $43.44 $149,797 - $193,264
4,449 Added 90.57%
9,361 $322,000
Q3 2021

Oct 18, 2021

BUY
$30.65 - $35.68 $132,162 - $153,852
4,312 Added 718.67%
4,912 $160,000
Q2 2021

Aug 06, 2021

SELL
$34.33 - $44.68 $85,825 - $111,700
-2,500 Reduced 80.65%
600 $21,000
Q4 2020

Jan 25, 2021

BUY
$36.63 - $47.63 $10,989 - $14,289
300 Added 10.71%
3,100 $135,000
Q3 2020

Oct 20, 2020

BUY
$30.09 - $43.02 $50,551 - $72,273
1,680 Added 150.0%
2,800 $109,000
Q2 2020

Jul 27, 2020

BUY
$27.76 - $33.42 $19,709 - $23,728
710 Added 173.17%
1,120 $36,000
Q1 2020

Apr 17, 2020

BUY
$20.69 - $37.79 $2,275 - $4,156
110 Added 36.67%
410 $12,000
Q3 2019

Oct 17, 2019

BUY
$33.73 - $46.27 $2,361 - $3,238
70 Added 30.43%
300 $10,000
Q3 2018

Oct 16, 2018

SELL
$35.69 - $47.65 $13,562 - $18,107
-380 Reduced 62.3%
230 $9,000
Q2 2018

Jul 19, 2018

BUY
$28.41 - $42.41 $5,966 - $8,906
210 Added 52.5%
610 $23,000
Q1 2018

Apr 10, 2018

SELL
$21.18 - $33.78 $2,118 - $3,378
-100 Reduced 20.0%
400 $12,000
Q3 2017

Oct 13, 2017

BUY
$19.61 - $23.35 $9,805 - $11,675
500
500 $11,000

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.56B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.